DK2287317T3 - Fremgangsmåde til fremstilling af en proteinester eller en ester af en proteinunderenhed - Google Patents

Fremgangsmåde til fremstilling af en proteinester eller en ester af en proteinunderenhed Download PDF

Info

Publication number
DK2287317T3
DK2287317T3 DK10178368.6T DK10178368T DK2287317T3 DK 2287317 T3 DK2287317 T3 DK 2287317T3 DK 10178368 T DK10178368 T DK 10178368T DK 2287317 T3 DK2287317 T3 DK 2287317T3
Authority
DK
Denmark
Prior art keywords
ala
seq
leu
gly
val
Prior art date
Application number
DK10178368.6T
Other languages
English (en)
Inventor
Kreij Arno De
Susan Mampusti Madrid
Jørn Dalgaard Mikkelsen
Jørn Borch Søe
Original Assignee
Dupont Nutrition Biosci Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43586988&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2287317(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB0301117.8A external-priority patent/GB0301117D0/en
Priority claimed from GBGB0301122.8A external-priority patent/GB0301122D0/en
Priority claimed from GB0301118A external-priority patent/GB0301118D0/en
Priority claimed from GB0301121A external-priority patent/GB0301121D0/en
Priority claimed from GB0301119A external-priority patent/GB0301119D0/en
Priority claimed from GB0301120A external-priority patent/GB0301120D0/en
Priority claimed from GBGB0330016.7A external-priority patent/GB0330016D0/en
Application filed by Dupont Nutrition Biosci Aps filed Critical Dupont Nutrition Biosci Aps
Application granted granted Critical
Publication of DK2287317T3 publication Critical patent/DK2287317T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A21BAKING; EDIBLE DOUGHS
    • A21DTREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D8/00Methods for preparing or baking dough
    • A21D8/02Methods for preparing dough; Treating dough prior to baking
    • A21D8/04Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
    • A21D8/042Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters
    • AHUMAN NECESSITIES
    • A21BAKING; EDIBLE DOUGHS
    • A21DTREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D13/00Finished or partly finished bakery products
    • A21D13/04Products made from materials other than rye or wheat flour
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C13/00Cream; Cream preparations; Making thereof
    • A23C13/12Cream preparations
    • A23C13/16Cream preparations containing, or treated with, microorganisms, enzymes, or antibiotics; Sour cream
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C15/00Butter; Butter preparations; Making thereof
    • A23C15/12Butter preparations
    • A23C15/123Addition of microorganisms or cultured milk products; Addition of enzymes; Addition of starter cultures other than destillates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C19/00Cheese; Cheese preparations; Making thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C19/00Cheese; Cheese preparations; Making thereof
    • A23C19/02Making cheese curd
    • A23C19/032Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A23C19/0328Enzymes other than milk clotting enzymes, e.g. lipase, beta-galactosidase
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C23/00Other dairy products
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • A23C9/1216Other enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01Other fatty acid esters, e.g. phosphatides
    • A23D7/013Spread compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G9/00Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
    • A23G9/32Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
    • A23G9/36Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G9/363Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L15/00Egg products; Preparation or treatment thereof
    • A23L15/25Addition or treatment with microorganisms or enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/60Salad dressings; Mayonnaise; Ketchup
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06Enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/10Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11Plant sterols or derivatives thereof, e.g. phytosterols
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/195Proteins from microorganisms
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11CFATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/10Ester interchange
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/1029Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436Fatty acid esters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436Fatty acid esters
    • C12P7/6445Glycerides
    • C12P7/6458Glycerides by transesterification, e.g. interesterification, ester interchange, alcoholysis or acidolysis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436Fatty acid esters
    • C12P7/6445Glycerides
    • C12P7/6481Phosphoglycerides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y203/00Acyltransferases (2.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y203/00Acyltransferases (2.3)
    • C12Y203/01Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003Triacylglycerol lipase (3.1.1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01026Galactolipase (3.1.1.26)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01032Phospholipase A1 (3.1.1.32)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/91045Acyltransferases (2.3)
    • G01N2333/91051Acyltransferases other than aminoacyltransferases (general) (2.3.1)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/918Carboxylic ester hydrolases (3.1.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Dairy Products (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Claims (20)

1. Fremgangsmåde til fremstilling af en proteinester og/eller en ester af en proteinunderenhed, hvilken fremgangsmåde omfatter samblanding af en acyldonor, en acylacceptor og vand til fremstilling af et vandrigt miljø, der omfatter 5-98 % vand, hvor acyldonoren er et lipidsubstrat, der er udvalgt fra én eller flere af gruppen bestående af et phospholipid, et lysophospholipid, et triacylglycerid, et diglycerid, et glycolipid eller et lysoglycolipid, og acylacceptoren er et protein og/eller en proteinunderenhed; og etablering af kontakt mellem samblandingen og en lipid-acyltransferase, således at lipid-acyltransferasen katalyserer én eller begge af følgende reaktionsblandinger: alkoholyse eller transesterificering, hvor lipid-acyltransferasen, når den testes ved anvendelse af Transferase-assay i Buffersubstrat, har mindst 2 % acyltransferaseaktivitet; hvilket transferase-assay omfatter trinnene med: i) opløsning af 450 mg phosphatidylcholin og 50 mg cholesterol i chloroform, inddampning til tørhed under vakuum; ii) overføring af 300 mg cholesterol/phosphatidylcholinblanding til et Wheaton-glas, tilsætning af 15 ml 50 mM HEPES-buffer pH 7 og dispergering af væsken i bufferen under omrøring; iii) opvarmning af substratet til 35 °C under omrøring med en magnetisk omrører og tilsætning af 0,25 ml enzymopløsning; iv) udtagning afprøver på 2 ml ved 0, 5, 10, 15, 25, 40 og 60 minutters reaktionstid og umiddelbar standsning af enzymreaktionen ved tilsætning af 25 μΐ 4M HC1 til forsuring af den frie fedtsyre; v) tilsætning af 3 ml chloroform og kraftig rystning i 30 sekunder, centrifugering og isolering af 2 ml af chloroformfasen, filtrering gennem et 0,45 μηι filter i et 10 ml tareret Dram-glas; vi) inddampning af chloroformen under en strøm af nitrogen ved 60 °C og vejning af prøverne; vi i) analyse af det ekstraherede lipid ved hjælp af GLC.
2. Fremgangsmåde ifølge krav 1, hvor lipid-acyltransferasen er immobiliseret.
3. Fremgangsmåde ifølge krav 1 eller krav 2, hvor fremgangsmåden omfatter oprensning af proteinesteren og/eller esteren af proteinunderenheden.
4. Fremgangsmåde ifølge et hvilket som helst af kravene 1-3, hvor lipid-acyltransferasen er kendetegnet ved at være et enzym, der har acyltransferase-aktivitet, og som omfatter aminosyresekvensmotivet GDSX, hvor X er én eller flere af følgende aminosyrerester L, A, V, I, F, Y, H, Q, T, N, M eller S.
5. Fremgangsmåde ifølge krav 1, hvor lipid-acyltransferaseensymet omfatter en aminosyreskevens der er fremstillet ved ekspression af én eller flere af følgende nukleotidsekvenser: (a) nukleotidsekvens ifølge SEQ ID NO: 7 (se figur 9); (b) nukleotidsekvens ifølge SEQ ID NO: 8 (se figur 10); (c) nukleotidsekvens ifølge SEQ ID NO: 9 (se figur 11); (d) nukleotidsekvens ifølge SEQ ID NO: 10 (se figur 12); (e) nukleotidsekvens ifølge SEQ ID NO: 11 (se figur 13); (f) nukleotidsekvens ifølge SEQ ID NO: 13 (se figur 15); (g) nukleotidsekvens ifølge SEQ ID NO: 21 (se figur 17); (h) nukleotidsekvens ifølge SEQ ID NO: 23 (se figur 19); (i) nukleotidsekvens ifølge SEQ ID NO: 25 (se figur 21); (j) nukleotidsekvens ifølge SEQ ID NO: 27 (se figur 23); (k) nukleotidsekvens ifølge SEQ ID NO: 29 (se figur 25); (l) nukleotidsekvens ifølge SEQ ID NO: 31 (se figur 27); (m) nukleotidsekvens ifølge SEQ ID NO: 33 (se figur 29); (n) nukleotidsekvens ifølge SEQ ID NO: 35 (se figur 31); (o) eller en nukleotidsekvens, der er 75 % eller mere identisk med en hvilken som helst af sekvenserne ifølge SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 21, SEQ ID NO: 23, SEQ ID NO: 25, SEQ ID NO: 27, SEQ ID NO:
29, SEQ ID NO: 31, SEQ ID NO: 33 eller SEQ ID NO: 35.
6. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvor lipid-acyltransferasen er klassificeret som E.C. 2.3.1.x.
7. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvor lipid-acyltransferasen kan opnås fra en organisme fta én eller flere af følgende arter: Aeromonas, Streptomyces, Saccharomyces, Lactococcus, Mycobacterium, Streptococcus, Lactobacillus, Desulfitobacterium, Bacillus, Campylobacter, Vibrionaceae, Xylella, Sulfolobus, Aspergillus, Schizosaccharomyces, Listeria, Neisseria, Mesorhizobium, Ralstonia, Xanthomonas og Candida.
8. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvor lipid-acyltransferasen omfatter én eller flere af følgende aminosyresekvenser: (i) aminosyresekvensen ifølge SEQ ID NO: 2; (ii) aminosyresekvensen ifølge SEQ ID NO: 3; (iii) aminosyresekvensen ifølge SEQ ID NO: 4; (iv) aminosyresekvensen ifølge SED ID NO: 5; (v) aminosyresekvensen ifølge SEQ ID NO: 6; (vi) aminosyresekvensen ifølge SEQ ID NO: 12, (vii) aminosyresekvensen ifølge SEQ ID NO: 20, (viii) aminosyresekvensen ifølge SEQ ID NO: 22, (ix) aminosyresekvensen ifølge SEQ ID NO: 24, (x) aminosyresekvensen ifølge SEQ ID NO: 26, (xi) aminosyresekvensen ifølge SEQ ID NO: 28, (xii) aminosyresekvensen ifølge SEQ ID NO: 30, (xiii) aminosyresekvensen ifølge SEQ ID NO: 32, (xiv) aminosyresekvensen ifølge SEQ ID NO: 34, eller en aminosyresekvens, der er 75 % eller mere identisk med en hvilken som helst af sekvenserne ifølge SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 12, SEQ ID NO: 20, SEQ ID NO: 22, SEQ ID NO:
24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, SEQ ID NO: 32 eller SEQ ID NO: 34.
9. Anvendelse af en lipid-acyltransferase til fremstilling af en proteinester og/eller en ester af en proteinunderenhed ved katalyse af én eller begge af alkoholyse eller transesterificering i en samblanding af en acyldonor, en acylacceptor og vand, hvilken samblanding omfatter 5-98 % vand, hvor acyldonoren er et lipidsubstrat udvalgt fra én eller flere af gruppen bestående af et phospholipid, et lysophospholipid, et triacylglycerid, et diglycerid, et glycolipid eller et lysoglycolipid, og acylacceptoren er et protein og/eller en proteinunderenhed, hvor lipid-acyltransferasen, når den testes ved anvendelse af et Transferase-assay i Buffersubstrat, har mindst 2 % acyltransferaseaktivitet; hvilket transferase-assay omfatter trinnene med: i) opløsning af 450 mg phosphatidylcholin og 50 mg cholesterol i chloroform, inddampning til tørhed under vakuum; ii) overføring af 300 mg cholesterol/phosphatidylcholinblanding til et Wheaton-glas, tilsætning af 15 ml 50 mM HEPES-buffer pH 7 og dispergering af væsken i bufferen under omrøring; iii) opvarmning af substratet til 35 °C under omrøring med en magnetisk omrører og tilsætning af 0,25 ml enzymopløsning; iv) udtagning afprøver på 2 ml ved 0, 5, 10, 15, 25, 40 og 60 minutters reaktionstid og umiddelbar standsning af enzymreaktionen ved tilsætning af 25 μΐ 4M HC1 til forsuring af den frie fedtsyre; v) tilsætning af 3 ml chloroform og kraftig rystning i 30 sekunder, centrifugering og isolering af 2 ml af chloroformfasen, filtrering gennem et 0,45 μηι filter i et 10 ml tareret Dram-glas; vi) inddampning af chloroformen under en strøm af nitrogen ved 60 °C, og vejning af prøverne; vii) analyse af det ekstraherede lipid ved hjælp af GLC.
10. Anvendelse ifølge krav 9, hvor lipid-acyltransferasen er immobiliseret.
11. Anvendelse ifølge krav 9, hvor proteinesteren og/eller esteren af proteinunderenheden er oprenset.
12. Anvendelse ifølge et hvilket som helst af kravene 9-11, hvor lipid-acyltransferasen er kendetegnet ved at være et enzym, der har acyltransferase-aktivitet, og som omfatter aminosyresekvensmotivet GDSX, hvor X er én eller flere af følgende aminosyrerester L, A, V, I, F, Y, H, Q, T, N, M eller S.
13. Anvendelse ifølge krav 9, hvor lipid-acyltransferaseenzymet omfatter en aminosyresekvens fremstillet ved ekspression af én eller flere af følgende nukleotidsekvenser: (a) nukleotidsekvens ifølge SEQ ID NO: 7 (se figur 9); (b) nukleotidsekvens ifølge SEQ ID NO: 8 (se figur 10); (c) nukleotidsekvens ifølge SEQ ID NO: 9 (se figur 11); (d) nukleotidsekvens ifølge SEQ ID NO: 10 (se figur 12); (e) nukleotidsekvens ifølge SEQ ID NO: 11 (se figur 13); (f) nukleotidsekvens ifølge SEQ ID NO: 13 (se figur 15); (g) nukleotidsekvens ifølge SEQ ID NO: 21 (se figur 17); (h) nukleotidsekvens ifølge SEQ ID NO: 23 (se figur 19); (i) nukleotidsekvens ifølge SEQ ID NO: 25 (se figur 21); (j) nukleotidsekvens ifølge SEQ ID NO: 27 (se figur 23); (k) nukleotidsekvens ifølge SEQ ID NO: 29 (se figur 25); (l) nukleotidsekvens ifølge SEQ ID NO: 31 (se figur 27); (m) nukleotidsekvens ifølge SEQ ID NO: 33 (se figur 29); (n) nukleotidsekvens ifølge SEQ ID NO: 35 (se figur 31); (o) eller en nukleotidsekvens, der er 75 % eller mere identisk med en hvilken som helst af sekvenserne ifølge SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 21, SEQ ID NO: 23, SEQ ID NO: 25, SEQ ID NO: 27, SEQ ID NO:
29, SEQ ID NO: 31, SEQ ID NO: 33 eller SEQ ID NO: 35.
14. Anvendelse ifølge et hvilket som helst af kravene 9 til 13, hvor lipid-acyltransferasen er klassificeret somE.C. 2.3.1.x
15. Anvendelse ifølge et hvilket som helst af kravene 9 til 14, hvor lipid-acyltransferasen kan opnås fra en organisme fra én eller flere af følgende arter: Aeromonas, Streptomyces, Saccharomyces, Lactococcus, Mycobacterium, Streptococcus, Lactobacillus, Desulfatobacterium, Bacillus, Campylobacter, Vibrionaceae, Xylella, Sulfolobus, Aspergillus, Schizosaccharomyces, Listeria, Neisseria, Mesorhizobium, Ralstonia, Xanthomonas og Candida.
16. Anvendelse ifølge et hvilket som helst af kravene 9-15, hvor lipid-acyltransferasen omfatter én eller flere af følgende aminosyresekvenser: (i) aminosyresekvensen ifølge SEQ ID NO: 2; (ii) aminosyresekvensen ifølge SEQ ID NO: 3; (iii) aminosyresekvensen ifølge SEQ ID NO: 4; (iv) aminosyresekvensen ifølge SEQ ID NO: 5; (v) aminosyresekvensen ifølge SEQ ID NO: 6; (vi) aminosyresekvensen ifølge SEQ ID NO: 12, (vii) aminosyresekvensen ifølge SEQ ID NO: 20, (viii) aminosyresekvensen ifølge SEQ ID NO: 22, (ix) aminosyresekvensen ifølge SEQ ID NO: 24, (x) aminosyresekvensen ifølge SEQ ID NO: 26, (xi) aminosyresekvensen ifølge SEQ ID NO: 28, (xii) aminosyresekvensen ifølge SEQ ID NO: 30, (xiii) aminosyresekvensen ifølge SEQ ID NO: 32, (xiv) aminosyresekvensen ifølge SEQ ID NO: 34, eller en aminosyresekvens, der er 75 % eller mere identisk med en hvilken som helst af sekvenserne ifølge SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 12, SEQ ID NO: 20, SEQ ID NO: 22, SEQ ID NO:
24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, SEQ ID NO: 32 eller SEQ ID NO: 34.
DK10178368.6T 2003-01-17 2004-01-15 Fremgangsmåde til fremstilling af en proteinester eller en ester af en proteinunderenhed DK2287317T3 (da)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GBGB0301117.8A GB0301117D0 (en) 2003-01-17 2003-01-17 Method
GBGB0301122.8A GB0301122D0 (en) 2003-01-17 2003-01-17 Method
GB0301118A GB0301118D0 (en) 2003-01-17 2003-01-17 Method
GB0301121A GB0301121D0 (en) 2003-01-17 2003-01-17 Method
GB0301119A GB0301119D0 (en) 2003-01-17 2003-01-17 Method
GB0301120A GB0301120D0 (en) 2003-01-17 2003-01-17 Method
US48944103P 2003-07-23 2003-07-23
GBGB0330016.7A GB0330016D0 (en) 2003-12-24 2003-12-24 Method
EP04702392A EP1599278B1 (en) 2003-01-17 2004-01-15 Method of producing a hydroxy acid ester

Publications (1)

Publication Number Publication Date
DK2287317T3 true DK2287317T3 (da) 2015-01-05

Family

ID=43586988

Family Applications (6)

Application Number Title Priority Date Filing Date
DK04702392.4T DK1599278T3 (da) 2003-01-17 2004-01-15 Fremgangsmåde til fremstilling af en hydroxysyreester
DK10178344.7T DK2278015T3 (da) 2003-01-17 2004-01-15 Fremgangsmåde til fremstilling af en carbohydratester
DK06014355.9T DK1748074T3 (da) 2003-01-17 2004-01-15 Fremgangsmåde til in situ-fremstilling af en emulgator i en fødevare
DK04702393.2T DK1619961T3 (da) 2003-01-17 2004-01-15 Fremgangsmåde til in situ-fremstilling af en emulgator i en fødevare
DK06014353.4T DK1762622T3 (da) 2003-01-17 2004-01-15 Fremgangsmåde til in situ produktionen af en emulgator i et næringsmiddel
DK10178368.6T DK2287317T3 (da) 2003-01-17 2004-01-15 Fremgangsmåde til fremstilling af en proteinester eller en ester af en proteinunderenhed

Family Applications Before (5)

Application Number Title Priority Date Filing Date
DK04702392.4T DK1599278T3 (da) 2003-01-17 2004-01-15 Fremgangsmåde til fremstilling af en hydroxysyreester
DK10178344.7T DK2278015T3 (da) 2003-01-17 2004-01-15 Fremgangsmåde til fremstilling af en carbohydratester
DK06014355.9T DK1748074T3 (da) 2003-01-17 2004-01-15 Fremgangsmåde til in situ-fremstilling af en emulgator i en fødevare
DK04702393.2T DK1619961T3 (da) 2003-01-17 2004-01-15 Fremgangsmåde til in situ-fremstilling af en emulgator i en fødevare
DK06014353.4T DK1762622T3 (da) 2003-01-17 2004-01-15 Fremgangsmåde til in situ produktionen af en emulgator i et næringsmiddel

Country Status (13)

Country Link
EP (8) EP2290085B1 (da)
JP (2) JP4804340B2 (da)
CN (2) CN102021206A (da)
AT (4) ATE487796T1 (da)
AU (2) AU2004206113B8 (da)
BR (5) BRPI0406770B1 (da)
CA (2) CA2511252C (da)
DE (1) DE602004032318D1 (da)
DK (6) DK1599278T3 (da)
ES (6) ES2661213T3 (da)
PT (3) PT1748074E (da)
SI (1) SI1619961T1 (da)
WO (2) WO2004064537A2 (da)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936289B2 (en) 1995-06-07 2005-08-30 Danisco A/S Method of improving the properties of a flour dough, a flour dough improving composition and improved food products
ES2168236T3 (es) 1997-04-09 2005-04-16 Danisco A/S Utilizacion de lipasa para mejorar las pastas de pan y los productos de panaderia.
ATE231186T1 (de) 1998-07-21 2003-02-15 Danisco Lebensmittel
BR0209154A (pt) 2001-05-18 2004-07-20 Danisco Processo de preparação de uma massa com uma enzima
US20050196766A1 (en) 2003-12-24 2005-09-08 Soe Jorn B. Proteins
DE602004030000D1 (de) 2003-01-17 2010-12-23 Danisco Verfahren zur in-situ-herstellung eines emulgators in einem nahrungsmittel
US7955814B2 (en) 2003-01-17 2011-06-07 Danisco A/S Method
BRPI0417533B1 (pt) 2003-12-24 2016-03-01 Danisco enzima variante glicolipídio aciltransferase, uso e método para sua produção, método para o preparo de um produto alimentício e produto assado de farinha, processo de refinamento enzimático
US7718408B2 (en) 2003-12-24 2010-05-18 Danisco A/S Method
WO2008090395A1 (en) * 2007-01-25 2008-07-31 Danisco A/S Production of a lipid acyltransferase from transformed bacillus licheniformis cells
GB0716126D0 (en) 2007-08-17 2007-09-26 Danisco Process
JP4949042B2 (ja) * 2003-12-24 2012-06-06 ダニスコ エイ/エス 食用油の酵素処理
US7906307B2 (en) 2003-12-24 2011-03-15 Danisco A/S Variant lipid acyltransferases and methods of making
NZ547082A (en) * 2003-12-24 2009-07-31 Danisco Enzymatic treatment of oils
GB0405637D0 (en) 2004-03-12 2004-04-21 Danisco Protein
CN101052702B (zh) 2004-07-16 2013-01-09 杜邦营养生物科学有限公司 脂肪分解酶及其在食品工业中的应用
US7462697B2 (en) * 2004-11-08 2008-12-09 Epitomics, Inc. Methods for antibody engineering
US8012724B2 (en) 2005-06-13 2011-09-06 Novozymes A/S Production of degummed fatty acid alkyl esters using both lipase and phospholipase in a reaction mixture
US20090246316A1 (en) * 2005-09-13 2009-10-01 Suntory Limited Esterase gene and use thereof
EP1964917B1 (en) * 2005-12-09 2013-02-20 Suntory Holdings Limited Lipase from Tetrasphaera
WO2007113257A1 (en) * 2006-04-03 2007-10-11 Novozymes A/S Method for producing ice cream
JP4792339B2 (ja) * 2006-07-04 2011-10-12 ナガセケムテックス株式会社 麺類改質剤及び麺類改良用組成物
EP2069488A2 (en) 2006-10-03 2009-06-17 Novozymes A/S Lipolytic enzyme variants
CN101200754B (zh) * 2007-12-07 2010-06-02 中国农业科学院油料作物研究所 无溶剂系统中固定化全细胞酶催化生产植物甾醇酯的方法
MX2010007014A (es) * 2007-12-21 2010-09-30 Danisco Procedimiento para refinacion de aceite comestible utilizando una lipido aciltransferasa.
GB0807161D0 (en) * 2008-04-18 2008-05-21 Danisco Process
EP2387330B1 (en) 2009-01-16 2017-11-15 DuPont Nutrition Biosciences ApS Enzymatic generaltion of functional lipids from cereal bran extract
GB0905367D0 (en) * 2009-03-27 2009-05-13 Danisco Method
JP5528535B2 (ja) 2009-03-31 2014-06-25 ダニスコ・アクティーゼルスカブ 植物細胞壁材料の可溶化の際の抽出物の暗色化および悪臭形成の防止
MX2011012860A (es) 2009-06-05 2012-01-25 Ajinomoto Kk Preparacion de enzimas para reformar productos de carne procesados y metodo de fabricacion para productos de carne procesada.
CA2766009A1 (en) 2009-06-25 2010-12-29 Danisco A/S Variant lipolytic enzymes with improved expression, functionality and/or activity
CN102656264A (zh) * 2009-10-15 2012-09-05 丹尼斯科公司 脂质酰基转移酶蛋白及其制备方法
GB0920089D0 (en) 2009-11-17 2009-12-30 Danisco Method
CN102844418B (zh) 2010-03-12 2015-11-25 杜邦营养生物科学有限公司 方法
WO2011114251A1 (en) 2010-03-18 2011-09-22 Danisco A/S Foodstuff
GB201007668D0 (en) 2010-05-07 2010-06-23 Danisco Method
BR112012032176A2 (pt) 2010-06-17 2015-09-08 Dupont Nutrition Biosci Aps processo de tratamento de sementes que contém óleo, método de obtenção de óleo de sementes vegetais, processo de produção de um óleo vegetal refinado e óleo vegetal bruto ou refinado que pode ser obtido por meio de um método ou processo
WO2012049180A1 (en) 2010-10-13 2012-04-19 Novozymes A/S Processing of oils and fats
AR084876A1 (es) 2011-01-21 2013-07-10 Novozymes As Produccion de esteres alquilicos de acidos grasos
CA3004088A1 (en) 2011-02-23 2012-08-30 Dupont Nutrition Biosciences Aps Enzymatic treatment of plant oil
WO2012114232A1 (en) 2011-02-23 2012-08-30 Dupont Nutrition Biosciences Aps Process
WO2012175466A1 (en) * 2011-06-20 2012-12-27 Nestec S.A. Emulsion comprising lyso-phospholipids
WO2013104660A1 (en) 2012-01-13 2013-07-18 Dupont Nutrition Biosciences Aps Process for treating a plant oil comprising hydrolysing chlorophyll or a chlorophyll derivative and involving partial caustic neutralisation
WO2013104659A2 (en) 2012-01-13 2013-07-18 Dupont Nutrition Biosciences Aps Process
WO2013160372A1 (en) 2012-04-27 2013-10-31 Dupont Nutrition Biosciences Aps Process for treating plant oil involving addition of serial doses of chlorophyll or chlorophyll derivative degrading enzyme
CN103387975A (zh) * 2012-05-11 2013-11-13 上海天伟生物制药有限公司 一种固定化环脂肽酰基转移酶及其制备方法和用途
US20170121741A1 (en) 2014-04-01 2017-05-04 Dupont Nutrition Biosciences Aps Method for increasing crude palm oil yields
PL3023316T3 (pl) 2014-11-21 2018-01-31 Hartwall K Oy Ab Zespół dyszla holowniczego i zawierający go wózek transportowy
CN108138203B (zh) 2015-10-09 2022-07-26 诺维信公司 酶或非酶生物柴油精制方法
ES3010116T3 (en) 2016-06-16 2025-04-01 Novozymes As Reduction of phospholipids in phospholipid-containing oil material
EP3272864A1 (en) * 2016-07-20 2018-01-24 Paul Scherrer Institut Solid-phase immobilization of microbial transglutaminase mtg on microbeads for protein conjugation
NZ762376A (en) 2017-09-19 2022-08-26 Scherrer Inst Paul Transglutaminase conjugation method and linker
ES2910373T3 (es) * 2018-05-18 2022-05-12 Unilever Ip Holdings B V Composición alimenticia emulsionada
JP7252733B2 (ja) * 2018-10-29 2023-04-05 森永乳業株式会社 乳蛋白質加水分解物の製造方法
KR20230096052A (ko) 2020-10-25 2023-06-29 아라리스 바이오테크 아게 항체-링커 접합체를 생성하기 위한 수단 및 방법
EP4334467A1 (en) 2021-05-04 2024-03-13 Novozymes A/S Enzymatic treatment of feedstock for hydrotreated vegetable oil (hvo) production

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
GB1525929A (en) 1974-11-25 1978-09-27 Unilever Ltd Stabilised emulsions comprising phospholipoprotein
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4581240A (en) 1979-07-30 1986-04-08 Smith Gerald W Process for increasing yield of cheese curd
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4544017A (en) 1982-03-18 1985-10-01 The University College Of Swansea Use of a hydraulic squeeze film to lubricate the strand in continuous casting
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP0138763B1 (en) 1983-10-04 1989-01-18 IntraCel Corporation Process for moulding gels usable for thin layers electrophoresis
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
DK122686D0 (da) 1986-03-17 1986-03-17 Novo Industri As Fremstilling af proteiner
US4959229A (en) 1988-12-12 1990-09-25 Reddy Malireddy S Cheese manufacture
WO1991006661A1 (en) * 1989-11-03 1991-05-16 Opta Food Ingredients, Inc. Lipase-catalyzed in situ generation of mono- and di-glycerides
DK19991D0 (da) 1991-02-06 1991-02-06 Novo Nordisk As Proteinpraeparationer
KR100225087B1 (ko) 1990-03-23 1999-10-15 한스 발터라벤 피타아제의 식물내 발현
DK0531372T4 (da) 1990-05-09 2004-08-09 Novozymes As Cellulasepræparat omfattende et endoglucanaseenzym
DE4112440C1 (da) 1991-04-16 1992-10-22 Diagen Institut Fuer Molekularbiologische Diagnostik Gmbh, 4000 Duesseldorf, De
HK1001951A1 (en) 1991-05-03 1998-07-24 Raisio Benecol Ltd. A substance for lowering high cholesterol level in serum and a method for preparing the same
EP0585988B1 (en) 1992-07-27 1996-03-13 Gist-Brocades N.V. Enzyme product and method for improving bread quality
DK104592D0 (da) 1992-08-21 1992-08-21 Novo Nordisk As Fremgangsmaade
JPH08504327A (ja) 1992-12-10 1996-05-14 ギスト ブロカデス ナムローゼ フェンノートシャップ 糸状菌における異種タンパクの生産
ZA943640B (en) 1993-06-07 1995-01-26 Buckman Labor Inc Synergistically stabilized liquid enzymatic compositions
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
JP3670284B2 (ja) 1994-02-21 2005-07-13 ノボザイムス アクティーゼルスカブ 固定化酵素調製品の製造方法および固定化酵素調製品の使用
US5741665A (en) 1994-05-10 1998-04-21 University Of Hawaii Light-regulated promoters for production of heterologous proteins in filamentous fungi
SE504366C2 (sv) 1995-05-08 1997-01-20 Dux Ind Ab Sätt och maskin för att åstadkomma en fjädermadrassbana
JP4053595B2 (ja) 1995-09-22 2008-02-27 メディカル・リサーチ・カウンシル 核酸の突然変異誘発におけるまたはそれに関する改良
FR2739860B1 (fr) 1995-10-17 1998-01-02 Coletica Complexes amphiphiles, procede pour leur preparation et compositions en renfermant
US6344328B1 (en) 1995-12-07 2002-02-05 Diversa Corporation Method for screening for enzyme activity
US6361974B1 (en) 1995-12-07 2002-03-26 Diversa Corporation Exonuclease-mediated nucleic acid reassembly in directed evolution
US5756328A (en) * 1995-12-20 1998-05-26 Cornell Research Foundation, Inc. Acyltransferase and cDNA encoding acyltransferase
US20010018514A1 (en) 1998-07-31 2001-08-30 Mcgall Glenn H. Nucleic acid labeling compounds
ES2168236T3 (es) 1997-04-09 2005-04-16 Danisco A/S Utilizacion de lipasa para mejorar las pastas de pan y los productos de panaderia.
ATE231186T1 (de) * 1998-07-21 2003-02-15 Danisco Lebensmittel
NZ511340A (en) 1998-11-27 2003-07-25 Novozymes As Lipolytic enzyme variants
AU4039400A (en) 1999-03-26 2000-10-16 Diversa Corporation Exonuclease-mediated nucleic acid reassembly in directed evolution
KR100854607B1 (ko) 1999-08-30 2008-08-27 몬산토 테크놀로지 엘엘씨 식물 스테롤 아실전달효소
DE19953854C2 (de) 1999-11-09 2002-01-17 Max Planck Gesellschaft Verfahren zur Herstellung von Biopolymeren mit veränderten Eigenschaften
GB9927801D0 (en) 1999-11-24 2000-01-26 Danisco Method
FI108204B (fi) 1999-11-25 2001-11-30 Kari Johannes Kirjavainen Kalvo energioiden muuntamiseksi
AU1723801A (en) 1999-12-03 2001-06-12 Danisco A/S Method of improving dough and bread quality
WO2002006457A2 (en) 2000-07-13 2002-01-24 Maxygen, Inc. Novel lipase genes
BR0209154A (pt) 2001-05-18 2004-07-20 Danisco Processo de preparação de uma massa com uma enzima
DE50115482D1 (de) * 2001-07-11 2010-06-24 Cognis Ip Man Gmbh Lipase/Acyltransferase aus Candida parapsilosis
EP1468084A1 (en) 2002-01-16 2004-10-20 Novozymes A/S Lipolytic enzyme variants and method for their production
WO2003097835A2 (en) 2002-05-16 2003-11-27 Molecular Engines Laboratories Pharmaceutical compositions for the treatment of cancer
SE0201581D0 (sv) 2002-05-29 2002-05-29 Scandinavian Biotechnology Res New improved acyltransferase

Also Published As

Publication number Publication date
EP1748074B1 (en) 2011-11-16
BRPI0406770A8 (pt) 2017-12-12
AU2004206113A1 (en) 2004-08-05
WO2004064537A3 (en) 2006-03-23
BRPI0419102B1 (pt) 2018-07-17
WO2004064987A2 (en) 2004-08-05
JP4804340B2 (ja) 2011-11-02
SI1619961T1 (sl) 2011-03-31
EP2278015A1 (en) 2011-01-26
WO2004064537A2 (en) 2004-08-05
BR122016015076B1 (pt) 2017-05-16
DK1748074T3 (da) 2012-03-05
EP1619961B1 (en) 2010-11-10
BRPI0406770A (pt) 2005-12-20
EP1748074A3 (en) 2007-05-23
CA2511252C (en) 2015-04-14
PT1762622E (pt) 2012-01-13
CN102021206A (zh) 2011-04-20
EP1762622A2 (en) 2007-03-14
WO2004064987A3 (en) 2006-03-23
EP2290085A2 (en) 2011-03-02
CA2511252A1 (en) 2004-08-05
EP1619961A2 (en) 2006-02-01
ES2521681T3 (es) 2014-11-13
ES2661213T3 (es) 2018-03-28
EP2287317B1 (en) 2014-10-22
EP2287317A3 (en) 2011-12-14
DK1619961T3 (da) 2011-01-17
JP2006521787A (ja) 2006-09-28
ES2375492T3 (es) 2012-03-01
ATE487796T1 (de) 2010-11-15
EP2287317A2 (en) 2011-02-23
EP2290085A3 (en) 2012-04-04
DK2278015T3 (da) 2014-10-13
CN102021205A (zh) 2011-04-20
AU2004206113B2 (en) 2009-09-03
EP3323887A2 (en) 2018-05-23
EP1599278A2 (en) 2005-11-30
EP1762622A3 (en) 2007-05-23
EP2290085B1 (en) 2017-12-13
ES2364654T3 (es) 2011-09-08
AU2004206113B8 (en) 2009-12-24
EP1762622B1 (en) 2011-11-16
BRPI0406602A (pt) 2006-03-01
CA2512734A1 (en) 2004-08-05
EP3323887A3 (en) 2018-09-12
JP2006524037A (ja) 2006-10-26
CA2512734C (en) 2012-06-19
PT1748074E (pt) 2012-01-16
AU2004205539A1 (en) 2004-08-05
BRPI0406770B1 (pt) 2018-03-27
DK1599278T3 (da) 2011-07-18
EP2278015B1 (en) 2014-08-13
BRPI0419102B8 (pt) 2018-10-23
ES2525711T3 (es) 2014-12-29
AU2004205539B2 (en) 2008-08-14
AU2004205539A2 (en) 2004-08-05
JP4778887B2 (ja) 2011-09-21
ATE533849T1 (de) 2011-12-15
DK1762622T3 (da) 2012-01-16
EP1748074A2 (en) 2007-01-31
EP1599278B1 (en) 2011-04-20
BRPI0419103B1 (pt) 2018-07-31
PT1619961E (pt) 2011-01-11
ATE533850T1 (de) 2011-12-15
ES2374132T3 (es) 2012-02-14
AU2004206113A2 (en) 2004-08-05
ATE506440T1 (de) 2011-05-15
DE602004032318D1 (de) 2011-06-01

Similar Documents

Publication Publication Date Title
DK2287317T3 (da) Fremgangsmåde til fremstilling af en proteinester eller en ester af en proteinunderenhed
US8278062B2 (en) Method of using lipid acyltransferase
JP5697294B2 (ja) 糖脂質アシル基転移酵素変異体及びその製造方法
EP1704240B1 (en) Enzymatic treatment of oils
US20120064192A1 (en) Enzymatic Oil-Degumming Method
JP2007516717A6 (ja) タンパク質
US8030044B2 (en) Lipid acyltransferases
RU2371474C2 (ru) Способ получения сложного эфира углерода, сложного эфира белка, сложного эфира белковой субъединицы или сложного эфира гидроксикислоты с использованием липидацилтрансферазы
RU2377307C2 (ru) Ферментативная обработка масел
HK1153509A (en) Method of producing a carbohydrate ester
HK1154268A (en) Method of producing a protein ester or a protein subunit ester
BR122016015093B1 (pt) Method for producing a protein ester and / or a protein subunity ester and use of an enzyme lipid aciltransferase for producing a protein ester and / or a protein subunit ester
HK1091868B (en) Enzymatic treatment of oils
MXPA06007423A (en) Proteins